Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Impact Regulatory News (PIM)

  • There is currently no data for PIM

Distribution Agreement

2 Jun 2010 07:00

RNS Number : 8611M
Plant Impact PLC
02 June 2010
 



 

Press release

02 June 2010

 

 

 

Plant Impact and Arysta LifeScience Reach Distribution Agreement for

Crop Nutrition Products in Central America

 

Plant Impact plc (AIM: PIM), which develops and markets ecologically friendly crop nutrition and protection products, announces that the company has signed a distribution agreement for InCa (named TALENTUSTM in Central America), Plant Impact's calcium delivery product, with Arysta LifeScience Mexico.

 

As part of the 10-year agreement, Arysta LifeScience will have exclusive distribution rights for sales and marketing of InCa in Mexico, Guatemala, Costa Rica, El Salvador, Honduras, Dominican Republic, Panama, Belize and parts of the Caribbean.

 

With InCa sales in Mexico to commence in third quarter 2010, Plant Impact has already received the first order for shipment in September 2010.

 

This is the first of a number of distribution agreements planned with Arysta LifeScience and demonstrates commercial progression as a result of the Evaluation, Development and Distribution agreement signed in February 2010. Arysta LifeScience Mexico has undertaken a substantial field trial programme for InCa, and further products are at an evaluation stage in Central America.

 

Plant Impact also is negotiating distribution agreements with Arysta LifeScience subsidiaries in Czech Republic and Romania. Arysta LifeScience Czech Republic took delivery of an order for InCa in May 2010.

 

Arysta LifeScience and Plant Impact are coordinating field trial activities, and the initial trial programme, which has already started, is concentrating on the US, Mexico, Brazil, Chile, Ivory Coast, South Africa, North Africa, Indonesia, Thailand, France, Poland, Romania and Czech Republic.

 

Peter Blezard, CEO of Plant Impact, commented: "Plant Impact continues to demonstrate commercial development with key partners like Arysta LifeScience. The relationship between the two companies is strong, with joint teams working on BugOil development, crop nutrient field trial development and commercialisation."

 

"We are excited about the opportunity to bring Plant Impact's innovative product platform to Central America, and soon, to other regions around the world through our significant global market development and distribution network," said Paula Pinto, global head of marketing at Arysta LifeScience."

 

Enquiries:

 

For further information, please contact:

Plant Impact Plc

Peter Blezard, Chief Executive Office Mike Panteli, Chief Financial Officer

 

+44 (0) 1772 645 164 +44 (0) 1772 645 165

Allenby Capital Limited - Nominated Adviser and Broker

Nick Naylor / Alex Price

+44 (0) 20 3328 5656

Conduit PR - Financial PR/IR

Charlie Geller

+44 (0) 20 7429 6604

 

- Ends - 

About Arysta LifeScience Corporation

Headquartered in Tokyo, Japan, Arysta LifeScience is the world's largest privately held crop protection and life science company with 2009 revenues of JPY112 billion (US$1.2 billion). An entrepreneurial provider of crop protection and life science products in more than 125 countries worldwide, Arysta LifeScience specializes in marketing and distribution of respected crop protection brands and life science products in harmony with the needs of global partners. More information on the company is available at: www.arystalifescience.com.

 

About Plant Impact plc

Plant Impact develops and markets ecologically friendly crop nutrition and crop protection products. These products improve crop yields by reducing plant stresses caused by temperature, salinity, drought and light. The Company sells its products directly and through licensing agreements with international agrochemical companies. The Directors believe that Plant Impact is differentiated from its competitors by marketing effective and environmentally friendly products.

 

Plant Impact has four key technologies marketed initially to the high value fruit and vegetable crop sectors; Bug Oil, CaT, PiNT and Speedo. The next two years will be dominated by CaT and PiNT sales to existing markets, and BugOil milestone payments in advance of its international roll out through Arysta, a global top ten agrochemical company.

 

For further information please visit www.plantimpact.com

 

About InCa

 

InCa is a product derived from Plant Impact's CaT technology. This technology is a calcium absorption aid. In trials it has been found to deliver calcium to the plant up to 50 times more effectively than traditional calcium products and with fewer applications and less input.

 

CaT alleviates the problems encountered by growing crops under environmental stress (drought, heat, cold) and physiological diseases in the ongoing development of the fruit that are often due to calcium deficiencies. This technology enables calcium uptake and retention in the tissues of the plant that would not naturally absorb calcium under normal growing conditions.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRUGUMCQUPUGPG
Date   Source Headline
14th Dec 20172:48 pmRNSForm 8.3 - Plant Impact PLC
14th Dec 20172:17 pmRNSForm 8.3 - Plant Impact plc
14th Dec 201712:00 pmRNSForm 8.5 (EPT/RI) Plant Impact Plc
13th Dec 20177:00 amRNSUpdate, Strategic Options and Formal Sale Process
24th Oct 20177:00 amRNSPosting of Annual Report and Notice of AGM
17th Oct 20175:27 pmRNSNotification of Major Holdings
9th Oct 20177:00 amRNSPreliminary Results
27th Sep 20177:00 amRNSNotice of Preliminary Results
20th Sep 20172:40 pmRNSNotification of Major Holdings
15th Aug 20177:00 amRNSR&D Platform and Pipeline Presentation
2nd Aug 20178:46 amRNSTR-1: Notification of Major Holdings
1st Aug 20174:46 pmRNSTR-1: Notification of major holdings
1st Aug 201710:42 amRNSTOTAL VOTING RIGHTS
31st Jul 20173:48 pmRNSNOTIFICATION OF MAJOR HOLDINGS
28th Jul 20173:59 pmRNSDirector/PDMR Shareholding
28th Jul 20173:48 pmRNSNotification of Major Interest in Shares
28th Jul 20173:43 pmRNSNotification of Major Interest in Shares
26th Jul 20173:25 pmRNSBLOCK LISTING SIX MONTHLY RETURN
26th Jul 20177:00 amRNSProposed Placing
17th Jul 20177:00 amRNSFull Year Trading Update & Potential Capital Raise
19th Jun 20177:00 amRNSThird Quarter Trading Update
3rd May 20177:00 amRNSNew collaboration with Ghent University
6th Mar 20177:00 amRNSHalf year results
22nd Feb 20175:00 pmRNSUSA launch of Fortalis®
8th Feb 20177:00 amRNSNew Quality Standard
12th Jan 20177:30 amRNSBLOCK LISTING SIX MONTHLY RETURN
12th Jan 20177:00 amRNSCORRECTION OF BLOCK LISTING SIX MONTHLY RETURN
9th Dec 20162:17 pmRNSRESULTS OF ANNUAL GENERAL MEETING
9th Dec 20167:00 amRNSAGM Trading Update
2nd Dec 20167:00 amRNSTotal Voting Rights
10th Nov 20167:00 amRNSPosting of Annual Report and Notice of AGM
31st Oct 20167:00 amRNSPreliminary Results
19th Aug 20167:00 amRNSAdoption of FRS 101
3rd Aug 20165:03 pmRNSTotal Voting Rights
6th Jul 20167:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
1st Jul 20167:00 amRNSNew Product Intro & Launch of Southern Cone Ops
14th Jun 20167:00 amRNSTrading update
19th May 20167:00 amRNSOption Grant to Recently Appointed CFO
10th May 20167:00 amRNSAppointment of Chief Financial Officer
20th Apr 20167:00 amRNSScientific Advisory Network
6th Apr 20163:55 pmRNSDirector's Dealing
4th Apr 20168:26 amRNSTotal Voting Rights
21st Mar 20167:00 amRNSHalf yearly results
16th Mar 20167:00 amRNSCollaboration on mitigating heat stress in wheat
7th Mar 20167:00 amRNSNotification of Half Year Results
2nd Mar 20163:48 pmRNSTotal Voting Rights
24th Feb 20167:00 amRNSNotification of Major Interest in Shares
19th Feb 20165:19 pmRNSBlock Listing Six Monthly Return
18th Feb 20167:00 amRNSNorth America Operations: Key Senior Appointment
15th Feb 20162:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.